🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

113 results for “SUBSTANCE” Clear

  1. Outpatient MST/OPTION-A

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 1 other completed

    1 trial

  2. RDC-0313 + Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 1 small molecule completed

    1 trial

  3. Sugar Pill

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 1 small molecule completed

    1 trial

  4. Woebot Substance Use Disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 1 other completed

    1 trial

  5. radioactive substance

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 1 other active

    1 trial

  6. BUP microdose induction

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    approved small molecule terminated

    1 trial

  7. Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe

    LEO Pharma A/S

    Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

    approved small molecule active

    1 trial

  8. COLECALCIFEROL , The Placebo product consists only of pure Ph. Eur. refined olive and it differs from Test product for the absence of active substance only: therefore, there are no reasons to suspect that the placebo product will undergo changes in its physical characteristics or degradation., Placebo

    Fondazione Telethon ETS

    obese elderly people with vitamin D deficiency

    approved small molecule active

    1 trial

  9. Carvedilol NORMON 6.25 mg tablets EFG., Il n'a pas de substance active. Le produit est un comprimé pelliculé sécable blanc, de forme ovale, de longueur 8mm, avec une gravure F57 sur une face et une barre de sécabilité sur l’autre face. Excipients: Prosolv Easytab SP (Cellulose microcristalline, Silice colloïdale, Sodium starch glycolate, Sodium stéaryl fumarate). Solution de pelliculage: (Hypromellose, PEG 3350, Candurin silver sheen)

    Tour Hekla

    Asymptomatic Child-Pugh A5 to B8 cirrhosis

    approved small molecule active

    1 trial

  10. Desipramine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  11. Pegylated Interferon

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  12. Stimulant or sedative

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  13. The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon tsetis pharmaceutical laboratory s.a) and is not sterile., ALKACITRAT Αναβράζον δισκίο 2 g/tab

    Lacuna Pharma Pty Ltd

    Functional Dyspepsia

    approved small molecule active

    1 trial

  14. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial

  15. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  16. Nicotine Replacement Treatment (NRT)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    small molecule completed

    1 trial

  17. fMRI

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources